Journal article

Qpioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol

Amy Peacock, Briony Larance, Michael Farrell, Rose Cairns, Nicholas Buckley, Louisa Degenhardt

BMJ Open | BMJ PUBLISHING GROUP | Published : 2018


Awarded by NHMRC

Funding Acknowledgements

This work was supported by investigator-initiated untied educational funding from Seqirus Pty Ltd (the marketer of tapentadol SRF in Australia) granted to AP, BL, MF, RC, and LD. BL, AP and LD are supported by NHMRC research fellowships (#1073858, #1109366 and #1041472). The National Drug and Alcohol Research Centre at UNSW Australia is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund.